Lung Injury Prediction Study

NCT00889772 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2015-09-24

No results posted yet for this study

Summary

The purpose of the study is to externally validate the acute lung injury/acute respiratory distress syndrome (ALI/ARDS) prediction model (Lung Injury Prediction Score - LIPS) in a multicenter sample of patients at risk presented to the acute care hospitals: United States Critical Illness and Injury Trials Group (USCIITG).

Conditions

  • Respiratory Distress
  • Acute Lung Injury

Sponsors & Collaborators

  • Icahn School of Medicine at Mount Sinai

    collaborator OTHER
  • Temple University

    collaborator OTHER
  • Johns Hopkins University

    collaborator OTHER
  • University of Medicine and Dentistry of New Jersey

    collaborator OTHER
  • University of Colorado, Denver

    collaborator OTHER
  • University of Pennsylvania

    collaborator OTHER
  • Brigham and Women's Hospital

    collaborator OTHER
  • Boston University

    collaborator OTHER
  • University of Michigan

    collaborator OTHER
  • University of Texas Southwestern Medical Center

    collaborator OTHER
  • Providence Health & Services

    collaborator OTHER
  • University of Illinois at Chicago

    collaborator OTHER
  • Wake Forest University

    collaborator OTHER
  • Bridgeport Hospital

    collaborator OTHER
  • Massachusetts General Hospital

    collaborator OTHER
  • Beth Israel Deaconess Medical Center

    collaborator OTHER
  • Wright State University

    collaborator OTHER
  • University of Missouri-Columbia

    collaborator OTHER
  • Uludag University

    collaborator OTHER
  • Akdeniz University

    collaborator OTHER
  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Ognjen Gajic, M.D. · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2010-02-28
Completion
2010-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00889772 on ClinicalTrials.gov